Source Paper
Synaptic plasticity and learning: selective impairment of learning rats and blockade of long-term potentiation in vivo by the N-methyl-D- aspartate receptor antagonist AP5
Journal of Neuroscience • 1989
View Abstract
This paper reports a series of 5 experiments concerned with a possible role for N-methyl-D-aspartate (NMDA) receptors in certain types of learning. The results show that chronic intraventricular infusion of the NMDA receptor antagonist D,L-2-amino-5-phosphonopentanoic acid (D,L- AP5) caused an impairment of spatial but not of visual discrimination learning in rats. Such selectivity of the learning impairment occurred despite widespread distribution of the drug throughout the CNS. AP5 sometimes caused a disturbance of sensorimotor function during learning, but one experiment addressing whether this disturbance could be responsible for the spatial learning impairment established that it was statistically independent. Another experiment showed that AP5 did not affect the retention of previously acquired spatial information. These behavioral effects were all obtained with a concentration of AP5 that, in a final study, was found to be sufficient to block hippocampal long-term potentiation (LTP) in vivo without affecting normal synaptic transmission. Taken together, these observations (1) implicate NMDA receptors in certain types of learning, and (2) extend recent work showing that saturation of LTP causes an anterograde spatial amnesia (McNaughton et al., 1986). A preliminary report of parts of this work has been published (Morris et al., 1986a).
Visual Discrimination Learning Task
Objective: Assessment of visual discrimination learning ability in rats to compare with spatial learning impairment and determine selectivity of NMDA receptor antagonist effects on learning types
Gather these items before starting the experiment. Check off items as you prepare.
Equipment1
Not specified • Not specified • Not specified • Not specified
Materials1
Not specified • Not specified • Not specified • Not specified
As an Amazon Associate, we earn from qualifying purchases. Product links help support this free resource.
Protocol Steps
Drug Administration
Chronic intraventricular infusion of D,L-AP5 NMDA receptor antagonist
Note: Drug concentration was sufficient to block hippocampal long-term potentiation in vivo without affecting normal synaptic transmission
View evidence from paper
“chronic intraventricular infusion of the NMDA receptor antagonist D,L-2-amino-5-phosphonopentanoic acid (D,L-AP5)”
Visual Discrimination Learning Task
Assessment of visual discrimination learning ability in rats treated with AP5
Note: Task designed to compare learning performance with spatial learning impairment results
View evidence from paper
“chronic intraventricular infusion of the NMDA receptor antagonist D,L-2-amino-5-phosphonopentanoic acid (D,L-AP5) caused an impairment of spatial but not of visual discrimination learning in rats”
Sensorimotor Function Assessment
Evaluation of whether AP5-induced sensorimotor disturbances could account for spatial learning impairment
Note: Statistical analysis performed to determine independence of sensorimotor effects from spatial learning impairment
View evidence from paper
“AP5 sometimes caused a disturbance of sensorimotor function during learning, but one experiment addressing whether this disturbance could be responsible for the spatial learning impairment established that it was statistically independent”
Retention Testing
Assessment of retention of previously acquired spatial information in AP5-treated rats
Note: Designed to determine if AP5 affects memory consolidation or retrieval of already-learned spatial tasks
View evidence from paper
“Another experiment showed that AP5 did not affect the retention of previously acquired spatial information”
Hippocampal LTP Recording
In vivo recording of long-term potentiation in hippocampus to verify drug efficacy
Note: Confirmed that AP5 concentration used was sufficient to block hippocampal LTP without affecting normal synaptic transmission
View evidence from paper
“a final study, was found to be sufficient to block hippocampal long-term potentiation (LTP) in vivo without affecting normal synaptic transmission”